Patient Assistance Programs

The Medicines Company Patient Assistance Program currently provides ORBACTIV® (oritavancin) for Injection at no cost to qualified patients who are not insured through private insurance or government-funded healthcare programs, e.g. Medicare or Medicaid. Healthcare providers can submit an application on behalf of the patient.  Please continue to check back on this web page for updates regarding The Medicines Company Patient Assistance Program.

While The Medicines Company will make every effort to grant aid for requests that satisfy the eligibility criteria, this program is limited to available resources and may be discontinued or revised at any time. If you have any additional questions, please call the hotline listed on the right.

ORBACTIV® Patient Assistance
Hotline +1 844 672 2284
Fax +1 855 886 2482

Angiomax® Patient Assistance
The Medicines Company will discontinue the ANGIOMAX® (bivalirudin) for injection Patient Assistance Program (the "Program") at 6:00 PM EST on November 30, 2017. The Program will process any applications received before 6:00 PM EST on November 30, 2017, and will ship replenishment product upon a determination of eligibility subject to Program criteria. Please contact the hotline number at 1-800-756-6463 if you have any questions.